Effect of formalin fixation on measured concentrations of deposited gadolinium in human tissue: an autopsy study

Abstract

Background

Generally, studies of gadolinium (Gd) deposition in humans measure concentration by analyzing formalin fixed postmortem tissue. However, the effect of formalin fixation on measured Gd concentration has not been well investigated.

Purpose

To evaluate the effect of fixation by comparing Gd concentration in fresh versus formalin-fixed postmortem human tissues.

Material and Methods

Fresh samples of bone and skin were collected from autopsy cases with previous exposure to Gd-based contrast agents (GBCAs). The type of GBCA administered, dose, and estimated glomerular filtration rate were recorded. Each tissue sample was cut into three aliquots. Paired samples were stored fresh frozen while the remaining two were stored in 10% neutral buffered formalin for one and three months, respectively. Gd concentration was measured using ICP-MS.

Results

Of 18 autopsy cases studied, 12 were exposed to only macrocyclic GBCA, one to only linear agents, and five received both macrocyclic and linear agents. On average, Gd concentration for bone decreased 30.7% after one month of fixation (P = 0.043) compared to non-fixed values. There was minimal, if any, change in concentration between one and three months (average decrease 1.5%; P = 0.89). The findings were numerically similar for skin tissue with an average decrease of 36.9% after one month (P = 0.11) and 6.0% (P = 0.73) between one and three months.

Conclusion

Formalin fixation appears to decrease Gd concentration in bone and skin by approximately 30%–40% on average. The largest decrease occurs within the first 30 days of fixation followed by a considerably smaller decrease at 60 days.

Keywords

Magnetic resonance imaging gadolinium deposition formalin fixation decreased renal function gadolinium-based contrast agents

Get full access to this article

View all access options for this article.

References

Hao

Goerner

, et al. MRI contrast agents: basic chemistry and safety. J Magn Reson Imaging 2012; 36:1060–1071.

Thomsen

Morcos

Almen

, et al. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 2013; 23:307–318.

Murata N, Gonzalez-Cuyar LF, Murata K, Fligner C, Dills R, Hippe D, et al. Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: preliminary results from 9 patients with normal renal function. Invest Radiol 2016;51:447–453.

McDonald

Dai

, et al. Comparison of gadolinium concentrations within multiple rat organs after intravenous administration of linear versus macrocyclic gadolinium chelates. Radiology 2017; 285:536–545.

Murata N, Murata K, Gonzalez-Cuyar LF, et al. Gadolinium tissue deposition in brain and bone. Magn Reson Imaging 2016;34:1359–1365.

McDonald

Kallmes

, et al. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 2015; 275:772–782.

Kanda

Fukusato

Matsuda

, et al. Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 2015; 276:228–232.

Kanda

Ishii

Kawaguchi

, et al. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 2014; 270:834–841.

Gibby

WA.

Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy.

Invest Radiol 2004; 39:138–142.

10.

Darrah

Prutsman-Pfeiffer

Poreda

, et al. Incorporation of excess gadolinium into human bone from medical contrast agents. Metallomics 2009; 1:479–488.

11.

Roberts

Welsh

LeBel

2nd , et al. Distribution map of gadolinium deposition within the cerebellum following GBCA administration. Neurology 2017; 88:1206–1208.

12.

Birka

Wentker

Lusmoller

, et al. Diagnosis of nephrogenic systemic fibrosis by means of elemental bioimaging and speciation analysis. Anal Chem 2015; 87:3321–3328.

13.

Sarafanov

Todorov

Kajdacsy-Balla

, et al. Analysis of iron, zinc, selenium and cadmium in paraffin-embedded prostate tissue specimens using inductively coupled plasma mass-spectrometry. J Trace Elem Med Biol 2008; 22:305–314.

14.

Gambino

James

Buchweitz

, et al. Retention of gadolinium in the brains of healthy dogs after a single intravenous administration of gadodiamide. Am J Vet Res 2018; 79:949–960.